{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:19:03Z","timestamp":1787937543787,"version":"build-2784847793"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"DOI":"10.7759\/cureus.115356","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:35:30Z","timestamp":1787934930000},"source":"Crossref","is-referenced-by-count":0,"title":["Metastatic Carotid Body Paraganglioma Following Three Decades of Indolent Growth: A Case Report"],"prefix":"10.7759","author":[{"given":"Erik L","family":"Parkhurst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders JW","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, et al.. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014, 99:1915-42. 10.1210\/jc.2014-1498","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2010.10.017","article-title":"Metastatic paraganglioma","volume":"37","author":"Fliedner SM","year":"2010","unstructured":"Fliedner SM, Lehnert H, Pacak K. Metastatic paraganglioma. Semin Oncol. 2010, 37:627-37. 10.1053\/j.seminoncol.2010.10.017","journal-title":"Semin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac105","article-title":"Systematic review: incidence of pheochromocytoma and paraganglioma over 70 years","volume":"6","author":"Al Subhi AR","year":"2022","unstructured":"Al Subhi AR, Boyle V, Elston MS. Systematic review: incidence of pheochromocytoma and paraganglioma over 70 years. J Endocr Soc. 2022, 6:bvac105. 10.1210\/jendso\/bvac105","journal-title":"J Endocr Soc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14222","article-title":"Bilateral pheochromocytoma: clinical characteristics, treatment and longitudinal follow-up","volume":"93","author":"Kittah NE","year":"2020","unstructured":"Kittah NE, Gruber LM, Bancos I, et al.. Bilateral pheochromocytoma: clinical characteristics, treatment and longitudinal follow-up. Clin Endocrinol (Oxf). 2020, 93:288-95. 10.1111\/cen.14222","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14744\/SEMB.2020.18794","article-title":"Pheochromocytoma and paraganglioma: from epidemiology to clinical findings","volume":"54","author":"Aygun N","year":"2020","unstructured":"Aygun N, Uludag M. Pheochromocytoma and paraganglioma: from epidemiology to clinical findings. Sisli Etfal Hastan Tip Bul. 2020, 54:159-68. 10.14744\/SEMB.2020.18794","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-022-01216-4","article-title":"Neurological manifestations of paragangliomas of the head and neck","volume":"22","author":"Leonetti JP","year":"2022","unstructured":"Leonetti JP. Neurological manifestations of paragangliomas of the head and neck. Curr Neurol Neurosci Rep. 2022, 22:485-9. 10.1007\/s11910-022-01216-4","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s002689900139","article-title":"Clinical spectrum and outcome of functional extraadrenal paraganglioma","volume":"20","author":"O'Riordain DS","year":"1996","unstructured":"O'Riordain DS, Young WF Jr, Grant CS, Carney JA, van Heerden JA. Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg. 1996, 20:916-22. 10.1007\/s002689900139","journal-title":"World J Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders JW","year":"2005","unstructured":"Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005, 366:665-75. 10.1016\/S0140-6736(05)67139-5","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1126\/science.1175689","article-title":"SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma","volume":"325","author":"Hao HX","year":"2009","unstructured":"Hao HX, Khalimonchuk O, Schraders M, et al.. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science. 2009, 325:1139-42. 10.1126\/science.1175689","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70007-3","article-title":"SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma","volume":"11","author":"Bayley JP","year":"2010","unstructured":"Bayley JP, Kunst HP, Cascon A, et al.. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol. 2010, 11:366-72. 10.1016\/S1470-2045(10)70007-3","journal-title":"Lancet Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1353.015","article-title":"Familial nonsyndromic pheochromocytoma","volume":"1073","author":"Opocher G","year":"2006","unstructured":"Opocher G, Schiavi F, Iacobone M, et al.. Familial nonsyndromic pheochromocytoma. Ann N Y Acad Sci. 2006, 1073:149-55. 10.1196\/annals.1353.015","journal-title":"Ann N Y Acad Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma","volume":"23","author":"Amar L","year":"2005","unstructured":"Amar L, Bertherat J, Baudin E, et al.. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol. 2005, 23:8812-8. 10.1200\/JCO.2005.03.1484","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02714.x","article-title":"Phaeochromocytoma, new genes and screening strategies","volume":"65","author":"Gimenez-Roqueplo AP","year":"2006","unstructured":"Gimenez-Roqueplo AP, Lehnert H, Mannelli M, et al.. Phaeochromocytoma, new genes and screening strategies. Clin Endocrinol (Oxf). 2006, 65:699-705. 10.1111\/j.1365-2265.2006.02714.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref14","article-title":"Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"Gimenez-Roqueplo AP","year":"2003","unstructured":"Gimenez-Roqueplo AP, Favier J, Rustin P, et al.. Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas. Cancer Res. 2003, 63:5615-21.","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081813","article-title":"Clinical and pathological tools for predicting recurrence and\/or metastasis in patients with pheochromocytoma and paraganglioma","volume":"10","author":"Bima C","year":"2022","unstructured":"Bima C, Bioletto F, Lopez C, et al.. Clinical and pathological tools for predicting recurrence and\/or metastasis in patients with pheochromocytoma and paraganglioma. Biomedicines. 2022, 10:1813. 10.3390\/biomedicines10081813","journal-title":"Biomedicines"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0189","article-title":"Management of endocrine disease: recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis","volume":"175","author":"Amar L","year":"2016","unstructured":"Amar L, Lussey-Lepoutre C, Lenders JW, Djadi-Prat J, Plouin PF, Steichen O. Management of endocrine disease: recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis. Eur J Endocrinol. 2016, 175:R135-45. 10.1530\/EJE-16-0189","journal-title":"Eur J Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01968","article-title":"Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-prono study): a European network for the study of adrenal tumors retrospective study","volume":"104","author":"Hescot S","year":"2019","unstructured":"Hescot S, Curras-Freixes M, Deutschbein T, et al.. Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-prono study): a European network for the study of adrenal tumors retrospective study. J Clin Endocrinol Metab. 2019, 104:2367-74. 10.1210\/jc.2018-01968","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-07-0074","article-title":"The diagnosis and management of malignant phaeochromocytoma and paraganglioma","volume":"14","author":"Chrisoulidou A","year":"2007","unstructured":"Chrisoulidou A, Kaltsas G, Ilias I, Grossman AB. The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr Relat Cancer. 2007, 14:569-85. 10.1677\/ERC-07-0074","journal-title":"Endocr Relat Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60060914","article-title":"Paragangliomas of the head and neck: a review of the latest diagnostic and treatment methods","volume":"60","author":"Palade DO","year":"2024","unstructured":"Palade DO, Hainarosie R, Zamfir A, et al.. Paragangliomas of the head and neck: a review of the latest diagnostic and treatment methods. Medicina (Kaunas). 2024, 60:914. 10.3390\/medicina60060914","journal-title":"Medicina (Kaunas)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.10.002","article-title":"Paraganglioma of the head and neck: a review","volume":"29","author":"Sandow L","year":"2023","unstructured":"Sandow L, Thawani R, Kim MS, Heinrich MC. Paraganglioma of the head and neck: a review. Endocr Pract. 2023, 29:141-7. 10.1016\/j.eprac.2022.10.002","journal-title":"Endocr Pract"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26277","article-title":"Head and neck paragangliomas: 30-year experience","volume":"42","author":"Valero C","year":"2020","unstructured":"Valero C, Ganly I, Shah JP. Head and neck paragangliomas: 30-year experience. Head Neck. 2020, 42:2486-95. 10.1002\/hed.26277","journal-title":"Head Neck"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/2473974X221086872","article-title":"Local tumor behavior associated with survival among patients with paraganglioma of the head and neck","volume":"6","author":"Harley RJ","year":"2022","unstructured":"Harley RJ, Lee JH, Ostrander BT, et al.. Local tumor behavior associated with survival among patients with paraganglioma of the head and neck. OTO Open. 2022, 6:2473974X221086872. 10.1177\/2473974X221086872","journal-title":"OTO Open"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3171\/2010.3.SPINE09459","article-title":"Reliability analysis of the epidural spinal cord compression scale","volume":"13","author":"Bilsky MH","year":"2010","unstructured":"Bilsky MH, Laufer I, Fourney DR, et al.. Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine. 2010, 13:324-8. 10.3171\/2010.3.SPINE09459","journal-title":"J Neurosurg Spine"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1612259","article-title":"Case report: Rare multisystem metastasis in head and neck paraganglioma with SDHB pathogenic variant and KIF1B VUS manifested as FUO","volume":"16","author":"Yang Y","year":"2025","unstructured":"Yang Y, Tian X, Jia C, Fan H, Li T, Zhang L, Liu Z. Case report: Rare multisystem metastasis in head and neck paraganglioma with SDHB pathogenic variant and KIF1B VUS manifested as FUO. Front Endocrinol (Lausanne). 2025, 16:1612259. 10.3389\/fendo.2025.1612259","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10252","article-title":"National Cancer Data Base report on malignant paragangliomas of the head and neck","volume":"94","author":"Lee JH","year":"2002","unstructured":"Lee JH, Barich F, Karnell LH, Robinson RA, Zhen WK, Gantz BJ, Hoffman HT. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer. 2002, 94:730-7. 10.1002\/cncr.10252","journal-title":"Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1224771","article-title":"Catecholamine-secreting paragangliomas: recent progress in diagnosis and perioperative management","volume":"19","author":"Colen TY","year":"2009","unstructured":"Colen TY, Mihm FG, Mason TP, Roberson JB. Catecholamine-secreting paragangliomas: recent progress in diagnosis and perioperative management. Skull Base. 2009, 19:377-85. 10.1055\/s-0029-1224771","journal-title":"Skull Base"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1530\/EO-22-0080","article-title":"Paragangliomas of the head and neck: a contemporary review","volume":"2","author":"Graham NJ","year":"2022","unstructured":"Graham NJ, Smith JD, Else T, Basura GJ. Paragangliomas of the head and neck: a contemporary review. Endocr Oncol. 2022, 2:R153-62. 10.1530\/EO-22-0080","journal-title":"Endocr Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.706","article-title":"Contemporary management of paragangliomas of the head and neck","volume":"7","author":"Cleere EF","year":"2022","unstructured":"Cleere EF, Martin-Grace J, Gendre A, Sherlock M, O'Neill JP. Contemporary management of paragangliomas of the head and neck. Laryngoscope Investig Otolaryngol. 2022, 7:93-107. 10.1002\/lio2.706","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44673","article-title":"Treatment of a non-syndromic carotid body paraganglioma using fast neutron radiotherapy: a case report and review of literature","volume":"15","author":"Ramanathan S","year":"2023","unstructured":"Ramanathan S, Loving BA, Fontanesi J. Treatment of a non-syndromic carotid body paraganglioma using fast neutron radiotherapy: a case report and review of literature. Cureus. 2023, 15:e44673. 10.7759\/cureus.44673","journal-title":"Cureus"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-017-0803-4","article-title":"Paragangliomas of the head and neck: an overview from diagnosis to genetics","volume":"11","author":"Williams MD","year":"2017","unstructured":"Williams MD. Paragangliomas of the head and neck: an overview from diagnosis to genetics. Head Neck Pathol. 2017, 11:278-87. 10.1007\/s12105-017-0803-4","journal-title":"Head Neck Pathol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2013.06.005","article-title":"Current and future trends in the anatomical and functional imaging of head and neck paragangliomas","volume":"43","author":"Ta\u00efeb D","year":"2013","unstructured":"Ta\u00efeb D, Varoquaux A, Chen CC, Pacak K. Current and future trends in the anatomical and functional imaging of head and neck paragangliomas. Semin Nucl Med. 2013, 43:462-73. 10.1053\/j.semnuclmed.2013.06.005","journal-title":"Semin Nucl Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/01455613221127585","article-title":"Multifocal paraganglioma including the cervical sympathetic chain","volume":"104","author":"Razmi S","year":"2025","unstructured":"Razmi S, Mohyuddin N. Multifocal paraganglioma including the cervical sympathetic chain. Ear Nose Throat J. 2025, 104:243S-6S. 10.1177\/01455613221127585","journal-title":"Ear Nose Throat J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.anorl.2016.10.003","article-title":"Morphological and functional imaging of neck paragangliomas","volume":"134","author":"Guichard JP","year":"2017","unstructured":"Guichard JP, Fakhry N, Franc J, Herman P, Righini CA, Taieb D. Morphological and functional imaging of neck paragangliomas. Eur Ann Otorhinolaryngol Head Neck Dis. 2017, 134:243-8. 10.1016\/j.anorl.2016.10.003","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1248","article-title":"Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma","volume":"94","author":"Timmers HJ","year":"2009","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA, et al.. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2009, 94:4757-67. 10.1210\/jc.2009-1248","journal-title":"J Clin Endocrinol Metab"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0333","article-title":"Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy","volume":"96","author":"King KS","year":"2011","unstructured":"King KS, Chen CC, Alexopoulos DK, et al.. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. J Clin Endocrinol Metab. 2011, 96:2779-85. 10.1210\/jc.2011-0333","journal-title":"J Clin Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4103\/ijnm.ijnm_66_22","article-title":"Ga-68 DOTATATE PET\/CT in the evaluation of paragangliomas and other indeterminate lesions in the head and neck","volume":"37","author":"Kuker R","year":"2022","unstructured":"Kuker R, Wang J, Nagornaya N, Bhatia RG, Quencer R, Serafini A. Ga-68 DOTATATE PET\/CT in the evaluation of paragangliomas and other indeterminate lesions in the head and neck. Indian J Nucl Med. 2022, 37:350-8. 10.4103\/ijnm.ijnm_66_22","journal-title":"Indian J Nucl Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Ta\u00efeb D","year":"2019","unstructured":"Ta\u00efeb D, Hicks RJ, Hindi\u00e9 E, et al.. European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2019, 46:2112-37. 10.1007\/s00259-019-04398-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000949","article-title":"The role of 68Ga-DOTATATE positron emission tomography\/computed tomography in well-differentiated neuroendocrine tumors: a case-based approach illustrates potential benefits and challenges","volume":"47","author":"Raj N","year":"2018","unstructured":"Raj N, Reidy-Lagunes D. The role of 68Ga-DOTATATE positron emission tomography\/computed tomography in well-differentiated neuroendocrine tumors: a case-based approach illustrates potential benefits and challenges. Pancreas. 2018, 47:1-5. 10.1097\/MPA.0000000000000949","journal-title":"Pancreas"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1238274","article-title":"Pheochromocytomas, PASS, and immunohistochemistry","volume":"41","author":"Carlsen E","year":"2009","unstructured":"Carlsen E, Abdullah Z, Kazmi SM, Kousparos G. Pheochromocytomas, PASS, and immunohistochemistry. Horm Metab Res. 2009, 41:715-9. 10.1055\/s-0029-1238274","journal-title":"Horm Metab Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000056982.07160.E3","article-title":"KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma","volume":"16","author":"Elder EE","year":"2003","unstructured":"Elder EE, Xu D, H\u00f6\u00f6g A, et al.. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma. Mod Pathol. 2003, 16:246-55. 10.1097\/01.MP.0000056982.07160.E3","journal-title":"Mod Pathol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-022-01435-8","article-title":"Update from the 5th Edition of the World Health Organization classification of head and neck tumors: overview of the 2022 WHO classification of head and neck neuroendocrine neoplasms","volume":"16","author":"Mete O","year":"2022","unstructured":"Mete O, Wenig BM. Update from the 5th Edition of the World Health Organization classification of head and neck tumors: overview of the 2022 WHO classification of head and neck neuroendocrine neoplasms. Head Neck Pathol. 2022, 16:123-42. 10.1007\/s12105-022-01435-8","journal-title":"Head Neck Pathol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-020-09618-1","article-title":"The diagnostic dilemma of GATA3 immunohistochemistry in pheochromocytoma and paraganglioma","volume":"31","author":"Kimura N","year":"2020","unstructured":"Kimura N, Shiga K, Kaneko K, Sugisawa C, Katabami T, Naruse M. The diagnostic dilemma of GATA3 immunohistochemistry in pheochromocytoma and paraganglioma. Endocr Pathol. 2020, 31:95-100. 10.1007\/s12022-020-09618-1","journal-title":"Endocr Pathol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1177\/0194599820902702","article-title":"Recurrence and progression of head and neck paragangliomas after treatment","volume":"162","author":"Contrera KJ","year":"2020","unstructured":"Contrera KJ, Yong V, Reddy CA, Liu SW, Lorenz RR. Recurrence and progression of head and neck paragangliomas after treatment. Otolaryngol Head Neck Surg. 2020, 162:504-11. 10.1177\/0194599820902702","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1604347","article-title":"Age and tumor volume predict growth of carotid and vagal body paragangliomas","volume":"78","author":"Heesterman BL","year":"2017","unstructured":"Heesterman BL, de Pont LM, Verbist BM, et al.. Age and tumor volume predict growth of carotid and vagal body paragangliomas. J Neurol Surg B Skull Base. 2017, 78:497-505. 10.1055\/s-0037-1604347","journal-title":"J Neurol Surg B Skull Base"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2012.37","article-title":"Natural history of cervical paragangliomas: outcomes of observation of 43 patients","volume":"138","author":"Langerman A","year":"2012","unstructured":"Langerman A, Athavale SM, Rangarajan SV, Sinard RJ, Netterville JL. Natural history of cervical paragangliomas: outcomes of observation of 43 patients. Arch Otolaryngol Head Neck Surg. 2012, 138:341-5. 10.1001\/archoto.2012.37","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(71)90436-3","article-title":"Carotid body tumor (chemodectoma): clinicopathologic analysis of ninety cases","volume":"122","author":"Shamblin WR","year":"1971","unstructured":"Shamblin WR, ReMine WH, Sheps SG, Harrison EG Jr. Carotid body tumor (chemodectoma): clinicopathologic analysis of ninety cases. Am J Surg. 1971, 122:732-9. 10.1016\/0002-9610(71)90436-3","journal-title":"Am J Surg"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2018.10.038","article-title":"A systematic review and meta-analysis of the presentation and surgical management of patients with carotid body tumours","volume":"57","author":"Robertson V","year":"2019","unstructured":"Robertson V, Poli F, Hobson B, Saratzis A, Ross Naylor A. A systematic review and meta-analysis of the presentation and surgical management of patients with carotid body tumours. Eur J Vasc Endovasc Surg. 2019, 57:477-86. 10.1016\/j.ejvs.2018.10.038","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-005-0968-4","article-title":"Does Shamblin's classification predict postoperative morbidity in carotid body tumors? A proposal to modify Shamblin's classification","volume":"263","author":"Luna-Ortiz K","year":"2006","unstructured":"Luna-Ortiz K, Rascon-Ortiz M, Villavicencio-Valencia V, Herrera-Gomez A. Does Shamblin's classification predict postoperative morbidity in carotid body tumors? A proposal to modify Shamblin's classification. Eur Arch Otorhinolaryngol. 2006, 263:171-5. 10.1007\/s00405-005-0968-4","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref49","article-title":"Carotid body and vagal paragangliomas: epidemiology, genetics, clinicopathological features, imaging, and surgical management","author":"Prasad SC","year":"2019","unstructured":"Prasad SC, Paties CT, Pantalone MR, Mariani-Costantini R, Sanna M. Carotid body and vagal paragangliomas: epidemiology, genetics, clinicopathological features, imaging, and surgical management. Paraganglioma: A Multidisciplinary Approach. Mariani-Costantini R  (ed): Codon Publications, Brisbane; 2019."},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2021.03.244","article-title":"Proposed modification to the Shamblin's classification of carotid body tumors: a single-center retrospective experience of 116 tumors","volume":"47","author":"Gu G","year":"2021","unstructured":"Gu G, Wu X, Ji L, et al.. Proposed modification to the Shamblin's classification of carotid body tumors: a single-center retrospective experience of 116 tumors. Eur J Surg Oncol. 2021, 47:1953-60. 10.1016\/j.ejso.2021.03.244","journal-title":"Eur J Surg Oncol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.4103\/ams.ams_183_18","article-title":"Carotid body paraganglioma","volume":"9","author":"Hosalkar RM","year":"2019","unstructured":"Hosalkar RM, Khivasara JS, Swain N. Carotid body paraganglioma. Ann Maxillofac Surg. 2019, 9:423-8. 10.4103\/ams.ams_183_18","journal-title":"Ann Maxillofac Surg"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1210\/er.2014-1026","article-title":"Current approaches and recent developments in the management of head and neck paragangliomas","volume":"35","author":"Ta\u00efeb D","year":"2014","unstructured":"Ta\u00efeb D, Kaliski A, Boedeker CC, Martucci V, Fojo T, Adler JR Jr, Pacak K. Current approaches and recent developments in the management of head and neck paragangliomas. Endocr Rev. 2014, 35:795-819. 10.1210\/er.2014-1026","journal-title":"Endocr Rev"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00133-5","article-title":"Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial","volume":"25","author":"Jimenez C","year":"2024","unstructured":"Jimenez C, Habra MA, Campbell MT, et al.. Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial. Lancet Oncol. 2024, 25:658-67. 10.1016\/S1470-2045(24)00133-5","journal-title":"Lancet Oncol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1220687","article-title":"Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001)","volume":"41","author":"Druce MR","year":"2009","unstructured":"Druce MR, Kaltsas GA, Fraenkel M, Gross DJ, Grossman AB. Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001). Horm Metab Res. 2009, 41:697-702. 10.1055\/s-0029-1220687","journal-title":"Horm Metab Res"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1287681","article-title":"Normal life expectancy for paraganglioma patients: a 50-year-old cohort revisited","volume":"21","author":"de Flines J","year":"2011","unstructured":"de Flines J, Jansen J, Elders R, et al.. Normal life expectancy for paraganglioma patients: a 50-year-old cohort revisited. Skull Base. 2011, 21:385-8. 10.1055\/s-0031-1287681","journal-title":"Skull Base"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/524720-metastatic-carotid-body-paraganglioma-following-three-decades-of-indolent-growth-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:35:31Z","timestamp":1787934931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/524720-metastatic-carotid-body-paraganglioma-following-three-decades-of-indolent-growth-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":55,"URL":"https:\/\/doi.org\/10.7759\/cureus.115356","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}